EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

κ-Opioid receptor activation suppresses triple-negative breast cancer progression by inducing urea cycle dysfunction and mitochondrial damage in vitro and in mice

Yumiao Shi, Yiying Tao, Zhiying Pan, Xiaoqiang Wang, Chaojin Zhang, Shujing Zhou, Daxiang Wen, Guojun Qian, Weifeng Yu, Jie Tian

British Journal of Anaesthesia · 2025-12 · 135 (6) · 1803-1815

DOI: 10.1016/j.bja.2025.07.093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Anaesthesia, 2025-12. Verfasst von Yumiao Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Anaesthesiology (Shanghai Jiao Tong University, Ministry of Education), Department of Anaesthesiology, Renji Hospital, Shanghai Jia…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Receptors, Opioid, kappa, Mitochondria, Urea. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Shanghai Municipality, Shanghai Engineering Technology Research Center, Special Funds for the Basic Research and Development Program in the Central Non-profit Research Institutes of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Triple-negative breast cancer (TNBC) is an aggressive malignancy with limited therapeutic options. Opioids are commonly used for perioperative and chronic pain management in patients with cancer. Notably, the κ-opioid receptor (KOR) has shown antitumour potential, but its therapeutic impact in TNBC is unknown. METHODS: We analysed KOR expression in TNBC patient cohorts and tissue microarrays. The effects of the KOR agonist U69593 were assessed on key malignant phenotypes in vitro, including apoptosis and mitochondrial integrity. We then validated its impact on tumour growth and metastasis using subcutaneous and haematogenous mouse models. RESULTS: KOR expression was downregulated in TNBC tissue (n=60, P=0.0004), and higher KOR levels were associated with more favourable patient prognosis (n=45 low vs 15 high, P=0.03). The KOR agonist U69593 suppressed TNBC progression both in vitro, by inhibiting cell proliferation, migration, and invasion while inducing apoptosis, and in vivo, by suppressing tumour growth and metastasis. U69593 induced severe mitochondrial damage, evidenced by loss of mitochondrial membrane potential and depleted intracellular adenosine triphosphate. Metabolomic profiling revealed that this was linked to disruption of the urea cycle, leading to the accumulation of toxic ammonia. Restoring urea cycle function by overexpression of the key enzyme ornithine transcarbamylase rescued TNBC cells from U69593-induced apoptosis and abrogated its antitumour effects. CONCLUSIONS: These findings demonstrate that the KOR agonist U69593 restrains TNBC progression by disrupting urea cycle function and compromising mitochondrial integrity, highlighting the potential of dual-action therapeutics that combine effective analgesia with direct antitumour activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsReceptors, Opioid, kappaMitochondriaUreaAnimalsMiceFemaleHumansDisease ProgressionCell Line, TumorApoptosisCell ProliferationMice, Nude

Stichwörter der Autor:innen

ammoniamitochondrial damagetriple-negative breast cancerurea cycleκ-opioid receptor

Substanzen

Receptors, Opioid, kappaUrea

Autor:innen und Institutionen

  • Key Laboratory of Anaesthesiology (Shanghai Jiao Tong University, Ministry of Education), Department of Anaesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Key Laboratory of Anaesthesiology (Shanghai Jiao Tong University, Ministry of Education), Department of Anaesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic addr…

Förderung

  • Natural Science Foundation of Shanghai Municipality
  • Shanghai Engineering Technology Research Center
  • Special Funds for the Basic Research and Development Program in the Central Non-profit Research Institutes of China
  • National Natural Science Foundation of China
  • Innovative Research Group Project of the National Natural Science Foundation of China
  • School of Medicine, Shanghai Jiao Tong University

Zitieren

APA

Shi, Y., Tao, Y., Pan, Z., Wang, X., Zhang, C., Zhou, S., Wen, D., Qian, G., Yu, W., & Tian, J. (2025). κ-Opioid receptor activation suppresses triple-negative breast cancer progression by inducing urea cycle dysfunction and mitochondrial damage in vitro and in mice. British Journal of Anaesthesia, 135(6), 1803-1815. https://doi.org/10.1016/j.bja.2025.07.093

Vancouver

Shi Y, Tao Y, Pan Z, Wang X, Zhang C, Zhou S, et al. κ-Opioid receptor activation suppresses triple-negative breast cancer progression by inducing urea cycle dysfunction and mitochondrial damage in vitro and in mice. British Journal of Anaesthesia. 2025;135(6):1803-1815. doi:10.1016/j.bja.2025.07.093

BibTeX
@article{Shi2025,
  author = {Shi, Yumiao and Tao, Yiying and Pan, Zhiying and Wang, Xiaoqiang and Zhang, Chaojin and Zhou, Shujing and Wen, Daxiang and Qian, Guojun and Yu, Weifeng and Tian, Jie},
  title = {κ-Opioid receptor activation suppresses triple-negative breast cancer progression by inducing urea cycle dysfunction and mitochondrial damage in vitro and in mice},
  journal = {British Journal of Anaesthesia},
  year = {2025},
  volume = {135},
  number = {6},
  pages = {1803--1815},
  doi = {10.1016/j.bja.2025.07.093}
}
Kostenlos starten →